Journal For Neurovirology

 

Volume 4, Number 2 (May 1998)

Reviews 

Targeting gene therapy vectors to CNS malignancies
Spear MA, Herrlinger U, Rainov N, Pechan P, Weissleder R, Breakefield XO.
pp. 133-147

(PDF)

The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target
Wikstrand CJ, Reist CJ, Archer GE, Zalutsky MR, Bigner DD.
pp. 148-158

(PDF)

Transgenic mice as research tools in neurocarcinogenesis
Rovigatti U, Afanasyeva T, Brandner S, Hainfellner JA, Kiess M, Maddalena A, Malin G, Rulicke T, Steinbach J, Weissenberger J, Aguzzi A.
pp. 159-174

(PDF)

Tumor pathogenesis of human neurotropic JC virus in the CNS
Gallia GL, Gordon J, Khalili K.
pp. 175-181

(PDF)

Papers 

Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans
Stewart AR, Lednicky JA, Butel JS.
pp. 182-193

(PDF)

Immune parameters affecting adenoviral vector gene therapy in the brain
Parr MJ, Wen PY, Schaub M, Khoury SJ, Sayegh MH, Fine HA.
pp. 194-203

(PDF)

Principles of treatment of malignant gliomas in adults: an overview
Azizi SA, Miyamoto C.
pp. 204-216

(PDF)

Differentially expressed gene products in glioblastoma cells suppressed for tumorigenicity
Ligon AH, Pershouse MA, Jasser S, Hong YK, Yung WK, Steck PA.
pp. 217-226

(PDF)

Management of malignant glioma: role of surgery in relation to multimodality therapy
Black P.
pp. 227-236

(PDF)

Short Communications 

Effects on brain tumor cell proliferation by an adenovirus vector that bears the interleukin-4 gene
Wei MX, Li F, Ono Y, Gauldie J, Chiocca EA.
pp. 237-241

(PDF)

Case Report 

PCR detection of JC virus DNA in the brain tissue of a 9-year-old child with pleomorphic xanthoastrocytoma
Boldorini R, Caldarelli-Stefano R, Monga G, Zocchi M, Mediati M, Tosoni A, Ferrante P.
pp. 242-245

(PDF)